抗发作药物的逐渐减少与皮质中白天的三角洲带功率减少有关
Guillermo M Besné1, Nathan Evans1, Mariella Panagiotopoulou1
1CNNP Lab (www.cnnp-lab.com), School of Computing, Newcastle University, Newcastle upon Tyne NE4 5TG, UK.
Brain communications
|February 26, 2025
概括
减少抗发作药物 (ASM) 在大多数患者中降低了三角带大脑活动. 这种在白天皮质区域的剂量依赖作用表明了ASM监测系统的潜力.
科学领域:
- 神经科学是一个神经科学.
- 的研究研究.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗发作药物 (ASM) 是治疗的基石.
- 药物对大脑活动的逐渐减少的影响,特别是以剂量,区域和时间依赖的方式,仍未得到充分研究.
- 了解这些影响对于临床实践和研究都至关重要.
研究的目的:
- 为了研究抗发作药物的剂量,区域和时间依赖的影响,逐渐减少内脑电图活动.
- 分析ASM的血水平与戒断期间大脑活动变化之间的关系.
- 探索这些发现的潜在临床应用.
主要方法:
- 分析了从32名接受长期监测的受试者的3000多小时的脑内电脑电图记录.
- 同时监测22名受试者的抗发作药物的逐渐减少.
- 使用已建立的药理动力学模型估计抗发作药物的血水平.
主要成果:
- 在80%的受试者中,在最大停药期间观察到带 (δ) 功率的整体下降,而不论类型或药物治疗方案.
- δ功率下降的幅度与抗发作药物戒断的程度正相关.
- 这种剂量依赖的效应在白天在皮质区域突出,但在皮质下区域或夜间没有突出.
结论:
- 在抗发作药物逐渐减少期间,带功率下降是一个一致的发现,与现有文献保持一致.
- 在皮层区域观察到的剂量依赖作用表明监测抗发作药物水平的可行性.
- 这些发现对开发药物提醒系统和闭环抗药物输送系统有影响,这些系统与更广泛的神经和精神疾病有关.
相关概念视频
01:17Antiepileptic Drugs: Calcium Channel Blockers
291
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
291
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
307
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
307
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
209
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
209
01:08Antiepileptic Drugs: Sodium Channel Blockers
347
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
347
01:20Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
01:24Arteries of the Lower Limbs
176
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
176